Consistent with GSEA findings, recombinant ASPN induced activating phosphorylation of HER2 in all prostate cancer cell lines analyzed (Figure 1H and Supplemental Figure 2, A–D). This evidence concerns the gene ERBB2 and Familial prostate cancer.